(Q71877966)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7611158%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

title

Comparison of lovastatin (20 mg) and nicotinic acid (1.2 g) with either drug alone for type II hyperlipoproteinemia (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7611158%20AND%20SRC:MED&resulttype=core&format=json

familial hypercholesterolemia 1

21 October 2019

main subject

1 reference

J. L. Vacek

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7611158

17 June 2024

G. Dittmeier

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7611158

17 June 2024

T. Chiarelli

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7611158

17 June 2024

J. White

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7611158

17 June 2024

H. H. Bell

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7611158

17 June 2024

language of work or name

English

0 references

publication date

1 July 1995

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7611158%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

15 July 1995

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=7611158

full work available at URL

17 June 2024

https://api.elsevier.com/content/article/PII:S0002914999800563?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0002-9149(99)80056-3

https://api.elsevier.com/content/article/PII:S0002914999800563?httpAccept=text/plain

17 June 2024

1 reference

https://api.crossref.org/works/10.1016/S0002-9149(99)80056-3

American Journal of Cardiology

17 June 2024

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7611158%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

volume

76

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7611158%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7611158%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

page(s)

182-184

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7611158%20AND%20SRC:MED&resulttype=core&format=json

Niacin revisited: clinical observations on an important but underutilized drug

21 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980056-3

New horizons in combination drug therapy for hypercholesterolemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980056-3

Beneficial effects of colestipol-niacin on coronary atherosclerosis. A 4-year follow-up

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980056-3

Raising HDL cholesterol with low-dose nicotinic acid and bezafibrate: preliminary experience

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980056-3

Long-term efficacy and safety of simvastatin alone and in combination therapy in treatment of hypercholesterolaemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980056-3

Marked decrease in serum HDL cholesterol levels by combined probucol-pravastatin treatment in hypercholesterolemic NIDDM patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980056-3

3-Hydroxy-3-methylglutaryl--coenzyme A reductase inhibitors in the treatment of hypercholesterolemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980056-3

HMG-CoA reductase inhibitors for treatment of hypercholesterolemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980056-3

An economic evaluation of lovastatin for cholesterol lowering and coronary artery disease reduction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980056-3

The efficacy of intensive dietary therapy alone or combined with lovastatin in outpatients with hypercholesterolemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980056-3

Myolysis and acute renal failure in a heart-transplant recipient receiving lovastatin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980056-3

Rhabdomyolysis in patients receiving lovastatin after cardiac transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980056-3

A comparison of the efficacy and toxic effects of sustained- vs immediate-release niacin in hypercholesterolemic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980056-3

Successful management of primary hypercholesterolaemia with simvastatin and low-dose colestipol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980056-3

inferred from DOI database lookup

7 January 2021

based on heuristic

Short- and long-term effects of lovastatin and pravastatin alone and in combination with cholestyramine on serum lipids, lipoproteins and apolipoproteins in primary hypercholesterolaemia

8

1 reference

https://api.crossref.org/works/10.1016/S0002-9149(99)80056-3

17 June 2024

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7611158%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

1 reference